These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 11389908)
1. The predicted beta12-beta13 loop is important for inhibition of PP2Acalpha by the antitumor drug fostriecin. Evans DR; Simon JA FEBS Lett; 2001 Jun; 498(1):110-5. PubMed ID: 11389908 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors. Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665 [TBL] [Abstract][Full Text] [Related]
3. Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors. Connor JH; Kleeman T; Barik S; Honkanen RE; Shenolikar S J Biol Chem; 1999 Aug; 274(32):22366-72. PubMed ID: 10428807 [TBL] [Abstract][Full Text] [Related]
4. Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition. Buck SB; Hardouin C; Ichikawa S; Soenen DR; Gauss CM; Hwang I; Swingle MR; Bonness KM; Honkanen RE; Boger DL J Am Chem Soc; 2003 Dec; 125(51):15694-5. PubMed ID: 14677930 [TBL] [Abstract][Full Text] [Related]
5. Crystal structure and mutagenesis of a protein phosphatase-1:calcineurin hybrid elucidate the role of the beta12-beta13 loop in inhibitor binding. Maynes JT; Perreault KR; Cherney MM; Luu HA; James MN; Holmes CF J Biol Chem; 2004 Oct; 279(41):43198-206. PubMed ID: 15280359 [TBL] [Abstract][Full Text] [Related]
6. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. Walsh AH; Cheng A; Honkanen RE FEBS Lett; 1997 Oct; 416(3):230-4. PubMed ID: 9373158 [TBL] [Abstract][Full Text] [Related]
7. The beta12-beta13 loop of protein phosphatase-1 is involved in activity regulation. Xie X; Xue C; Huang W; Wei Q IUBMB Life; 2006 Aug; 58(8):487-92. PubMed ID: 16916787 [TBL] [Abstract][Full Text] [Related]
8. Inhibitor-1 interaction domain that mediates the inhibition of protein phosphatase-1. Connor JH; Quan HN; Ramaswamy NT; Zhang L; Barik S; Zheng J; Cannon JF; Lee EY; Shenolikar S J Biol Chem; 1998 Oct; 273(42):27716-24. PubMed ID: 9765309 [TBL] [Abstract][Full Text] [Related]
10. Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity. Cheng A; Balczon R; Zuo Z; Koons JS; Walsh AH; Honkanen RE Cancer Res; 1998 Aug; 58(16):3611-9. PubMed ID: 9721869 [TBL] [Abstract][Full Text] [Related]
11. Suppression of Ser/Thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell death. Theobald B; Bonness K; Musiyenko A; Andrews JF; Urban G; Huang X; Dean NM; Honkanen RE Mol Cancer Res; 2013 Aug; 11(8):845-55. PubMed ID: 23671329 [TBL] [Abstract][Full Text] [Related]
12. Important role for phylogenetically invariant PP2Acalpha active site and C-terminal residues revealed by mutational analysis in Saccharomyces cerevisiae. Evans DR; Hemmings BA Genetics; 2000 Sep; 156(1):21-9. PubMed ID: 10978272 [TBL] [Abstract][Full Text] [Related]
13. Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters. Hastie CJ; Cohen PT FEBS Lett; 1998 Jul; 431(3):357-61. PubMed ID: 9714542 [TBL] [Abstract][Full Text] [Related]
14. Nuclear localization of protein phosphatase 5 is dependent on the carboxy-terminal region. Borthwick EB; Zeke T; Prescott AR; Cohen PT FEBS Lett; 2001 Mar; 491(3):279-84. PubMed ID: 11240142 [TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase 1 regulation by inhibitors and targeting subunits. Watanabe T; Huang HB; Horiuchi A; da Cruze Silva EF; Hsieh-Wilson L; Allen PB; Shenolikar S; Greengard P; Nairn AC Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3080-5. PubMed ID: 11248035 [TBL] [Abstract][Full Text] [Related]
16. Antitumor antibiotic fostriecin covalently binds to cysteine-269 residue of protein phosphatase 2A catalytic subunit in mammalian cells. Takeuchi T; Takahashi N; Ishi K; Kusayanagi T; Kuramochi K; Sugawara F Bioorg Med Chem; 2009 Dec; 17(23):8113-22. PubMed ID: 19857968 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells. Messner DJ; Romeo C; Boynton A; Rossie S J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789 [TBL] [Abstract][Full Text] [Related]
18. Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A. Roberge M; Tudan C; Hung SM; Harder KW; Jirik FR; Anderson H Cancer Res; 1994 Dec; 54(23):6115-21. PubMed ID: 7954457 [TBL] [Abstract][Full Text] [Related]
19. The beta12-beta13 loop is a key regulatory element for the activity and properties of the catalytic domain of protein phosphatase 1 and 2B. Xie XJ; Xue CZ; Huang W; Yu DY; Wei Q Biol Chem; 2006; 387(10-11):1461-7. PubMed ID: 17081120 [TBL] [Abstract][Full Text] [Related]
20. CRHSP-24 phosphorylation is regulated by multiple signaling pathways in pancreatic acinar cells. Schäfer C; Steffen H; Krzykowski KJ; Göke B; Groblewski GE Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G726-34. PubMed ID: 12801884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]